Partial
Partially Aligned
Patient Risk:
Moderate
Summary
Most statements correctly describe general COSENTYX live-vaccine immunization precautions and immune-risk framing, but several specific claims about MMR/inactivated vaccine effects and evidence/knowledge limits are not supported by the provided COSENTYX label excerpts.
Category Scores
Accurate Statements
People taking Cosentyx should consult their healthcare provider before receiving any live vaccine, including the MMR vaccine.
Supported by Section 5.7 (avoid use of live vaccines in patients treated with COSENTYX) and Section 17 (vaccination with live vaccines is not recommended during COSENTYX treatment).
Cosentyx may affect the immune system, which could potentially influence the response to live vaccines.
Supported by Section 5.7 (COSENTYX may alter a patient's immune response to live vaccines).
Evidence is limited regarding the safety of live vaccines, including MMR vaccine, in people taking biologics like Cosentyx.
Partially supported at most: the excerpts state COSENTYX may alter immune response and advise avoiding live vaccines, but do not provide specific evidence-limitation language about MMR or biologics.
Cosentyx may potentially lead to a reduced immune response to the MMR vaccine.
Partially supported: Section 5.7 states COSENTYX may alter a patient's immune response to live vaccines, but does not specifically mention reduced immune response to MMR.
Live vaccines like MMR vaccine can cause rare but potentially serious adverse reactions such as fever, rash, and thrombocytopenia.
Not supported by provided COSENTYX label excerpts (no MMR adverse reaction specifics in COSENTYX text provided).
Unsupported Statements
Evidence is limited regarding the safety of live vaccines, including MMR vaccine, in people taking biologics like Cosentyx.
Provided COSENTYX excerpts (5.7, 17) do not state that evidence is limited about safety of live vaccines, nor do they mention MMR specifically or biologics safety-evidence limitations.
Cosentyx may potentially lead to a reduced immune response to the MMR vaccine.
Label excerpt (5.7) supports that COSENTYX may alter immune response to live vaccines generally, but does not specifically claim reduced response to MMR.
Live vaccines like MMR vaccine can cause rare but potentially serious adverse reactions such as fever, rash, and thrombocytopenia.
No MMR-specific adverse reaction content is present in the provided COSENTYX label excerpts.
People taking Cosentyx may be at a higher risk for complications from live vaccines such as MMR vaccine.
Provided label excerpts advise to avoid live vaccines and that COSENTYX may alter immune response, but do not explicitly state higher risk of live-vaccine complications.
The long-term effects of combining Cosentyx with live vaccines, including the MMR vaccine, are not well understood.
No long-term combination/effect unknown language is present in the provided COSENTYX label excerpts.
Your healthcare provider may recommend waiting until you have completed Cosentyx treatment or switching to a different medication before receiving the MMR vaccine.
The excerpts provided state to avoid live vaccines during treatment, but do not mention waiting until completion, nor switching medications, nor any specific timing guidance.
An inactivated version of the MMR vaccine is not affected by Cosentyx.
Provided excerpts discuss live vaccines (avoid use) but do not state anything about inactivated MMR being unaffected by COSENTYX.
Contradictions
Important Omissions
Explicit statement from the label that live vaccines should be avoided during COSENTYX treatment (instead of only general counseling/consulting language).
Importance:
Moderate
Pre-treatment immunization counseling: consider completion of age-appropriate immunizations prior to initiating COSENTYX.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Several statements introduce MMR-specific adverse reaction risks and long-term/complication-risk assertions that are not supported by the provided COSENTYX label excerpts. While the core live-vaccine avoidance concept aligns with the label, unsupported specifics could mislead interpretation.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Partially Aligned
Primary Issue
Multiple claims reference MMR-specific adverse effects, higher complication risk, long-term uncertainty, and inactivated vaccine unaffectedness, none supported by the provided COSENTYX label excerpts.
Suggested Improvement
Limit claims to what the provided label states: COSENTYX may alter immune response to live vaccines and live vaccines should be avoided during treatment; advise considering completion of age-appropriate immunizations prior to initiating therapy (Section 5.7/17). Remove or rephrase MMR-specific and inactivated-vaccine-specific assertions unless supported by the actual label text not provided here.